Polyelectrolyte Stabilized Drug Nanoparticles via Flash Nanoprecipitation: A Model Study With β-Carotene

被引:86
作者
Zhu, Zhengxi [1 ]
Margulis-Goshen, Katrin [2 ]
Magdassi, Shlomo [2 ]
Talmon, Yeshayahu [3 ]
Macosko, Christopher W. [1 ]
机构
[1] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA
[2] Hebrew Univ Jerusalem, Inst Chem, Casali Inst Appl Chem, IL-91904 Jerusalem, Israel
[3] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel
基金
美国国家科学基金会;
关键词
nanoparticles; polymeric drug delivery systems; mixing; polyelectrolytes; formulation; nanosuspensions; biodegradable polymers; stabilization; supersaturation; light-scattering; INVERTING LAPLACE TRANSFORM; PROTECTED NANOPARTICLES; ORGANIC ACTIVES; CHITOSAN; PRECIPITATION; DISSOLUTION; DESIGN; MICRONIZATION; COMPLEXATION; DEGRADATION;
D O I
10.1002/jps.22090
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Polyelectrolyte protected beta-carotene nanoparticles (nanosuspensions) with average diameter of <100 nm were achieved by turbulent mixing and flash nanoprecipitation (FNP). Three types of multi-amine functional polyelectrolytes, epsilon-polylysine (epsilon-PL), poly(ethylene imine) (PEI), and chitosan, were investigated to electrosterically protect the nanoparticles. Particle size and distribution were measured by dynamic light scattering (DLS); particles were imaged via scanning electron microscopy (SEM) and cryogenic transmission electron microscopy (cryo-TEM). Low pH and high polyelectrolyte molecular weight gave the smallest and most stable particles. High drug loading capacity, >80 wt%, was achieved by using either PEI or chitosan. X-ray diffraction (XRD) patterns showed that beta-carotene nanoparticles were amorphous. These findings open the way for utilization of FNP for preparation of nanoparticles with enhanced bioavailability for highly water insoluble drugs. (C) 2010 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:4295-4306, 2010
引用
收藏
页码:4295 / 4306
页数:12
相关论文
共 63 条
  • [11] Viscoelastic properties of chitosan solutions:: Effect of concentration and ionic strength
    Cho, JY
    Heuzey, MC
    Bégin, A
    Carreau, PJ
    [J]. JOURNAL OF FOOD ENGINEERING, 2006, 74 (04) : 500 - 515
  • [12] Synthesis of poly(ε-lysine)-grafted dextrans and their pH- and thermosensitive hydrogelation with cyclodextrins
    Choi, HS
    Yamamoto, K
    Ooya, T
    Yui, N
    [J]. CHEMPHYSCHEM, 2005, 6 (06) : 1081 - 1086
  • [13] PH-DEPENDENT INTERACTIONS BETWEEN ADSORBED CHITOSAN LAYERS
    CLAESSON, PM
    NINHAM, BW
    [J]. LANGMUIR, 1992, 8 (05) : 1406 - 1412
  • [14] The design of nanoparticles obtained by solvent evaporation: A comprehensive study
    Desgouilles, S
    Vauthier, C
    Bazile, D
    Vacus, J
    Grossiord, JL
    Veillard, M
    Couvreur, P
    [J]. LANGMUIR, 2003, 19 (22) : 9504 - 9510
  • [15] An overview of current delivery systems in cancer gene therapy
    El-Aneed, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 2004, 94 (01) : 1 - 14
  • [16] Preparation of Poly(ethylene glycol) Protected Nanoparticles with Variable Bioconjugate Ligand Density
    Gindy, Marian E.
    Ji, Shengxiang
    Hoye, Thomas R.
    Panagiotopoulos, Athanassios Z.
    Prud'homme, Robert K.
    [J]. BIOMACROMOLECULES, 2008, 9 (10) : 2705 - 2711
  • [17] Composite block copolymer stabilized nanoparticles: Simultaneous encapsulation of organic actives and inorganic nanostructures
    Gindy, Marian E.
    Panagiotopoulos, Athanassios Z.
    Prud'homme, Robert K.
    [J]. LANGMUIR, 2008, 24 (01) : 83 - 90
  • [18] Poly(ethylenimine) and its role in gene delivery
    Godbey, WT
    Wu, KK
    Mikos, AG
    [J]. JOURNAL OF CONTROLLED RELEASE, 1999, 60 (2-3) : 149 - 160
  • [19] Polymer therapeutics: Concepts and applications
    Haag, R
    Kratz, F
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (08) : 1198 - 1215
  • [20] What is the true solubility advantage for amorphous pharmaceuticals?
    Hancock, BC
    Parks, M
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (04) : 397 - 404